Meaningfulness to patents with preclinical AD of thinking measured by digital cognitive tests in Trial Blazer‐Alz III clinical trial

Adults with preclinical AD did understand the type of cognition measured by the learning and memory tests (ISLT, CPAL) although the terms used to describe the varied. For the IDSSTm, most adults considered this to be an assessment of matching. Understanding of the how adults with preclinical; AD understand the types o thinking measured by neuropsychological test will help inform models of the clinical meaningfulness of any drug related benefits observed from trials in which they are being used.